CYP2B19, a member of the cytochrome P450 family, plays a pivotal role in cellular homeostasis by contributing to critical biochemical processes. The enzyme exhibits heme binding activity and monooxygenase activity, indicating its involvement in the oxidation of various substrates. Its predicted participation in the epoxygenase P450 pathway, steroid metabolism, and xenobiotic catabolism underscores its significance in the metabolism of endogenous compounds and the detoxification of exogenous substances. Located predominantly in the endoplasmic reticulum and membranes, CYP2B19 operates within the cytoplasm and intracellular membrane-bounded organelles, showcasing its versatile cellular functions. Activation of CYP2B19 involves a sophisticated interplay of cellular signaling pathways influenced by various chemicals. These activators, whether direct or indirect, modulate the enzyme's expression and activity through specific interactions with nuclear receptors and signaling molecules. The activation mechanisms are intricately tied to the regulatory networks governing cellular responses to environmental cues. For instance, certain chemicals act as agonists for nuclear receptors such as CAR, AhR, PXR, and PPARα, thereby initiating cascades of events that lead to the upregulation of CYP2B19 expression. The activation process often involves the modulation of transcriptional machinery, where activated receptors bind to specific response elements in the gene promoter region, promoting the synthesis of mRNA and subsequent translation of the enzyme. Indirect activators may exert their influence by altering chromatin structure, influencing the accessibility of transcriptional machinery to the CYP2B19 gene.
These complex activation mechanisms highlight the adaptability of CYP2B19 in responding to diverse environmental stimuli. The enzyme's expression in various bodily systems, including the alimentary, nervous, respiratory, sensory, and urinary systems, further emphasizes its integral role in maintaining cellular equilibrium. As a component of the intricate network of cellular processes, CYP2B19 contributes to the metabolic transformations necessary for cellular function and adaptation to external challenges. Understanding the nuanced activation mechanisms of CYP2B19 sheds light on its central role in cellular homeostasis and provides valuable insights into the regulatory networks governing xenobiotic metabolism and endogenous compound processing.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3-Methylcholanthrene | 56-49-5 | sc-252030 sc-252030A | 100 mg 250 mg | $388.00 $831.00 | 2 | |
Acting as an aryl hydrocarbon receptor (AhR) agonist, 3-Methylcholanthrene activates AhR, which subsequently induces CYP2B19 expression through the AhR/ARNT heterodimeric complex. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin, a potent inducer of the nuclear receptor PXR, stimulates CYP2B19 transcription. PXR activation leads to increased expression of CYP2B19, enhancing its metabolic activity. | ||||||
Aroclor 1254 | 11097-69-1 | sc-257096 | 50 mg | $143.00 | 1 | |
Aroclor 1254, a polychlorinated biphenyl, activates the AhR pathway, indirectly upregulating CYP2B19 expression through AhR-mediated transcriptional regulation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid receptor agonist, induces CYP2B19 expression through glucocorticoid receptor activation, leading to increased transcription and enzyme activity. | ||||||
β-Naphthoflavone | 6051-87-2 | sc-205597 sc-205597A sc-205597B sc-205597C | 1 g 5 g 25 g 100 g | $33.00 $129.00 $599.00 $1647.00 | 2 | |
As an AhR agonist, β-Naphthoflavone stimulates CYP2B19 expression through AhR-mediated signaling, influencing transcription and subsequent enzyme activation. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole activates PXR, leading to enhanced CYP2B19 expression. PXR-induced transcriptional upregulation is the mechanism through which omeprazole promotes the enzyme's activity. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate, a PPARα agonist, induces CYP2B19 expression through PPARα activation, resulting in increased transcription and subsequent upregulation of the enzyme. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Clotrimazole activates PXR, leading to increased CYP2B19 expression. PXR-mediated transcriptional upregulation is the mechanism through which clotrimazole enhances the enzyme's activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin indirectly upregulates CYP2B19 by inhibiting histone deacetylases, promoting a chromatin structure that facilitates increased transcription and subsequent enzyme activity. | ||||||